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Abstract The methylotrophic yeast Pichia pastoris was tested 
for heterologous expression of the mouse 5-HT~A receptor. Three 
different expression plasmids were constructed where the cDNA 
of the receptor was cloned under the transcriptional control of the 
highly inducible promotor of the P. pastoris alcohol oxidase 1 
(AOX1) gen. The expression plasmids differed with respect o the 
signal sequences used for N-terminal fusion. In two cases the 
coding region was additionally fused to the c-myc tag to permit 
immunological detection of the receptor. Expression of functional 
receptor after transformation of strain GSI15 was detected by 
radioligand binding using [3HILSD. The construct with the best 
expression levels in strain GS l l5  was used for transformation of 
the protease deficient strain SMDl163. Here, the expression 
level was 2-8 times higher. Whole cells as well as crude membrane 
preparations of recombinant clones showed saturable binding of 
[3H]LSD with a Kd of = 1.9 nM. Receptor concentrations of = 22 
pmol/mg membrane protein revealed the potential of the P. pasto- 
ris expression system for high level expression of membrane 
proteins. The pharmacological properties were comparable to 
those reported for the receptor expressed in mammalian systems. 
Key words': Pick& pastoris: Membrane protein; Heterologous 
expression; Mouse 5-HTsA receptor: Receptor affinity; 
Immunogold electron microscopy 
1. Introduction 
The methylotrophic yeast Pichia pastoris has been developed 
as a host for the efficient production of foreign proteins [1]. 
Interest in the Pichia pastoris expression system has grown, 
since this organism has the potential for high level expression 
and rapid growth to very high cell densities on inexpensive 
media [2,3]. A number of genes have already been heterolo- 
gously expressed using the promoter of the alcohol oxidase l 
(A OXI) gene of Pichia pastoris. A OXI is the first enzyme in the 
methanol-utilization pathway and is strongly regulated. The 
enzyme is undetectable when cells are cultured on carbon 
sources uch as glucose, glycerol or ethanol, but upon induction 
by addition of methanol it can constitute up to 30% of total 
soluble protein [4]. Stringent regulation of the A OXI is mainly 
achieved at the transcriptional level [5] and therefore, the pro- 
moter of the AOXI gene has been used as a powerful tool for 
the heterologous expression of genes which might otherwise be 
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Abbreviations: 5-CT, 5-carboxamidotryptamine: 5-HT. 5-hydroxytryp- 
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toxic to growing cells. In some cases, heterologous expression 
yielded up to several grams of the desired recombinant protein 
per liter of culture [6]. Although the P pastoris ystem has been 
successfully used for the production of many soluble proteins 
[7,8,9,10], reports on the successful heterologous expression of 
membrane proteins in this system are lacking. 
The mouse 5-HTsA receptor belongs to the large family of 
G-protein-coupled receptors which is of great pharmacological 
relevance. The receptor gene was cloned and characterized pre- 
viously [11]. The pharmacological profile of the receptor and 
sequence comparisons led to the assumption that the 5-HTsA 
receptor, together with the 5-HTsB receptor, defines a new 
subtype of serotonin receptors [12]. By in situ hybridization 
experiments expression of the 5-HTsA receptor gene could be 
detected only in different parts of the CNS (cerebral cortex, 
olfactory bulb, hippocampus, etc.) but not outside the CNS 
[11]. Until now, there has been a lack of knowledge concerning 
the effector pathway of the 5-HTs receptors. 
Like the majority of medical and pharmacological relevant 
membrane proteins, the 5-HTsA receptor is found naturally in 
only very small quantities. Therefore, overexpression f such 
proteins in a heterologous system and subsequent purification 
of the protein to homogeneity is a prerequisite for biophysical 
as well as structural studies [13]. The search for good expression 
systems for membrane proteins proved to be difficult, as pro- 
tein yields are often poor and therefore purification tends not 
to be worthwhile. As the 5-HTsA receptor could be functionally 
expressed in insect cells via the baculovirus expression system 
[14], as well as in the yeast S. cervisiae [15], we used this receptor 
to test the P pastoris system as a tool for membrane protein 
expression. 
2. Materials and methods 
2.1. Strains and transformations 
£ ~oli strain XL-1 Blue (Stratagene) was used for transformation [16] 
and propagation of the recombinant plasmids. Pichia pastoris train 
GSl15 (his4) and Pichia pastor& strain SMD1163 (his4, pep4, pbr) 
(lnvitrogen, San Diego) were used in the expression study. The strain 
SMD1163 bears a protease deficency. Yeast transformation was per- 
tbrmed according to the spheroplast method escribed in the Manual 
Version 3.0 of the Pichia Expression Kit (Invitrogen, San Diego). 
2.2. Recombinant DNA technology and construction fthe expression 
plasmid 
Plasmid constructions were performed using established techniques 
[16,17] and cloning steps were ensured by DNA sequencing [18]. 
2.2.1. pHIL-D2-5-HTsA. The 5-HTsA gene was isolated as a ~ 1.15 
kbp EcoRl fragment from the baculovirus transfer vector pVL935- 
HTsa [14] and ligated into the EcoRI site of vector pHIL-D2 (Invitro- 
gem San Diego). 
2.2.2. pHIL-S1-5-HT~Amyc. The 5-HTsA gene together with the se- 
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quence coding for the c-rove [19] epitope at its 5'-end, was isolated as 
a = 1.15 kbp BglII/BamHI fragment t¥om the baculovirus transfer vec- 
tor pVLMelMyc5-HTsA [14], and ligated into the BamHI side of vector 
pHIL-S1 (lnvitrogen, San Diego). The reading frame between the 
PHO1 secretion signal of the vector and the c-myc epitope was cor- 
rected by opening the Xhol side and a fill-in reaction with Klenow 
polymerase. The PHO1 signal sequence in vector pHIL-S1 was derived 
from the P pastoris acid phosphatase [9]. 
2.2.3. pPIC9-5-HT, AttO'c. The 5-HTsA gene, together with the se- 
quence coding for the c-myc epitope already fused to the 5' end of the 
receptor, was excised as a = 1.15 kb Bgill/EeoRI fragment from the 
plasmid pVLMelMyc5-HTsf , [14]. The reading frame was corrected by 
fill-in of the Bglll side. The fragment was ligated in the pPIC9 vektor 
(lnvitrogen, San Diego) using the SnaBl and EcoRI side. This chining 
step leads to an in-frame fusion of the c-mye tagged 5-HTsA receptor 
gene to the ~-factor signal sequence of S. cervisiae, which is encoded 
by the pPIC9 vector. 
In all resulting expression plasmids, the receptor gene was under the 
transcriptional control of the A OX1 promoter. The vectors were linear- 
ized before transformation with NotI (pHIL-D2-5-HT~A) or BgllI 
(pHIL-S1-5-HTsAmyc, pPIC9-5-HTsAmyc) to get Mut ~ (slow methanol 
utilization) transformants and with Sail to get Mut + (same methanol 
utilization as wild-type) transformants. 
2.3. Yeast cultures 
P pastoris strains were maintained and transformed as described m 
the Manual Version 3.0 of the Pichia Expression Kit (Invitrogen, San 
Diego). The Mut phenotype of recombinant clones was determined by 
patching His" transformants on minimal dextrose (1.34% yeast nitro- 
gen base with ammonium sulfate and without amino acids; 4 × 10-~% 
biotin and 1% dextrose) and minimal methanol (0.5% methanol instead 
of dextrose) plates. In Mut ~ transformants he AOX1 gene is replaced 
by the vector during transformation, resulting in strongly retarded 
growth on methanol. 
2.4. Isolation (?f crude membranes.lt'om E pastoris cells 
Cells were harvested 24 30 h alter induction by centrifugation, 
washed once with ice-cold breaking buffer (50 mM sodium phosphate. 
pH 7.4, 1 mM EDTA, 5% glycerol), and resuspended to an OD~0 of 
about 130 in breaking buffer supplemented with protease inhibitors (0.5 
mg/ml Pefabloc, 0.5/.tg/ml Leupeptin, 0.7/zg/ml Pepstatin). When pre- 
paring membranes from small cultures, an equal volume of glassbeads 
(Mesh 400-600; Sigma) was added to the suspension, and cells were 
broken by vigorous vortexing at 4°C for 5 min, with cooling on ice of 
the suspension every 30 s. When performing a large scale membrane 
preparation, cells were broken using a disintegrator. Intact cells and 
other crude particles were subsequently separated from the membrane 
suspension by a brief centrifugation step (700 x g, 10 min). Membranes 
were pelleted at 100,000 x g and 4°C for 30 min, and resuspended in 
50 mM Tris-HCl pH 7.4, 150 mM NaCI, 1 mM EDTA plus protease 
inhibitors (1/100 to 1/50 volume of the initial culture). Aliquots were 
snap-frozen and stored at -75°C for further analysis. The protein 
concentration of the membrane preparation was determined using the 
BCA method (Pierce, Rockford, IL). 
2.5. Radiol~eand binding assay 
Saturation and competition binding studies were performed as de- 
scribed previously [20]. The serotonin-specific ligand [3H]LSD was used 
in all studies (spec. act. 2.5~ 3.1 TBq/mmol; DuPont-NEN). Non-spe- 
cific binding was determined in the presence of 1 mM serotonin. Ka-and 
Bm,~-values were calculated by computer-aided non-linear egression 
analysis of the binding isotherms under equilibrium conditions. Com- 
petition displacement was performed in the presence of [3H]LSD at a 
final concentration f 1.6 nM and variable concentrations of the unla- 
beled drugs. For initial screening of recombinant clones, 2 12 × 10" 
whole cells of the respective clones were incubated as described betkwc. 
In this case a ligand concentration of 13 nM [~H]LSD was used. 
2.6. Fixation and embe~kfing jor #nmunogoht electron mk'roscopv 
Transformed cells of P pasloris were fixed, embedded and cut as 
described previously [20]. Thin sections were incubated with the pri- 
mary monoclonal ntibody 9EI0 (2 h, diluted 1 : 2000) directed against 
the c-myc tag. Goat anti-mouse antibodies (2 h) coupled to gold parti- 
cles (Amersham Buchler, Braunschweig) were used as secondary anti- 
bodies. After silver enhancement the final analysis was performed in the 
electron microscope CM12 (Philips, Eindhoven, The Netherlands). 
3. Results 
3.1. l@ctor constructions jor the heterologous expression of  the 
mouse 5-HTsA receptor in P. pastoris 
Three different plasmids for the heterologous expression of 
the 5-HTsA receptor were constructed (Fig. IA). In plasmid 
pHIL-D2-5-HTsA, the 5-HTsA cDNA has been cloned without 
modifications, whereas the other two constructs (pHIL-S1-5- 
HTsAmyc: pPIC9-5-HTsamyc) bore the coding region for a 
c-myc tagged 5-HTsA receptor fused to two different signal 
sequences. The use of signal sequences has been reported to 
enhance the expression of membrane receptors [21], and there- 
tore we tested two different signal sequences for their ability to 
enhance xpression of the receptor. The PHO1 signal sequence 
derived from the P. pastoris acid phosphatase [9] was utilized 
in the expression plasmid pHI L-S 1-5-HTsAmyc, whereas vector 
pPIC9-myc5-HTsA contained the S. cervisiae c~-factor signal 
sequence. The two signal sequences used in the different vectors 
have totally different properties. In contrast o classical signal 
sequences like the PH01 signal sequences, the 89 amino acids 
spanning the ~-factor signal sequence from S. cervisiae are not 
removed from the :z-factor in the endoplasmic reticulum like 
other signal peptides, but within the Golgi by the dibasic KEX2 
protease [22,23]. As has been reported previously, this cleavage 
also occurs efficiently in the heterologous urrounding of 
P pastoris [10]. Nevertheless, both constructions, after cleavage 
of the signal sequences, hould allow the immunological detec- 
tion of the heterologously produced protein which has been 
fused to the c-rove epitope. As mentioned above, the three 
vectors were linearized prior to transformation P. pastoris 
strain GS115 to obtain recombinant clones with different phe- 
notypes concerning methanol utilization. When the vectors 
pHIL-D2-5-HTsA, pHIL-SI-5-HTsAmyc and pPIC9-5- 
HTsAmyc were linearized with Notl or BgllI, respectively, 
about 10% of His + transformants showed a Mut ~ phenotype. 
After Sa/I-digestion of the vectors prior to transformation, 
ncarly all His + clones revealed a Mut + phenotype. 
3.2. Expression levels reached with the d![]erent transformed 
clones 
The expression levels of functional 5-HTsA receptor in re- 
combinant GS115 cells were significantly different for each of 
the three vectors as revealed by radioligand binding with the 
serotonergic ligand [3H]LSD on whole cells (Fig. I B). The ex- 
pression varied from clone to clone bearing the same expression 
casette, but no significant difference between clones with Mut S 
and those with Mut + phenotype could be detected. In general, 
the expression of the receptor was found to be best 2440 h 
alter induction with methanol. Recombinant clones derived 
alter transformation with plasmid pPIC9-5-HTsamyc showed 
the highest receptor densities (Fig. 1B), indicating that the ~- 
factor signal sequence improved expression in comparison to 
the construct with the PH01 signal sequence. Therefore, plas- 
mid pPIC9-5-HTsAmyc was used for transformation of P. pas- 
torts strain SM D1163. This strain bears mutations in two pro- 
tease genes whereas train GS l l  5 is wild-type in respect o its 
protease content. Ten recombinant clones with a Mut + pheno- 
type subsequently were analysed for receptor expression. Two 
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Fig. 1. (A) Expression plasmids constructed for heterologous expres- 
sion of the mouse 5-HTsA receptor in P pastoris. 5'AOX1, promotor 
of P pastoris alcoholoxidase 1 gen; SS-I. coding region for signal 
sequence from P pastoris acide phosphatase: SS-2, coding region for 
signal sequence from S. cerevisiae mating type factor m c-myc, coding 
region for the c-myc tag; 5-HT~A, c-DNA of the mouse 5-HTsA receptor. 
(B) Receptor densities achieved using this three expression plasmids 
with the third used in two different/3 pastoris trains. Standard evia- 
tions are indicated. The numbers in brackets indicate how many clones 
were analysed for receptor expression. 
recombinant clones exhibited only low receptor expression lev- 
els, whereas the other clones showed a 2 8 times higher recep- 
tor number per cell than the corresponding GSI 15-clones (Fig. 
IB). One clone which showed reproducible high expression 
level (22,000 32~000 receptors/cell, 24~,8 h after induction) was 
selected for further pharmacological characterization. 
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3.3. Pharmacological characterization of the 5-HTsA receptor 
produced in P. pastoris 
Neurotransmitter r ceptors are characterized bytheir ability 
to bind specific ligands with high affinities. Pharmacological 
classification ofa given receptor results finally from the ranking 
order of binding potency for certain ligands. In order to estab- 
lish the functional integrity of the 5-HTsA receptor heterolo- 
gously expressed in P. pastoris, ligand binding affinities were 
determined. Transformed yeast cells as well as membranes pre- 
pared here from were tested by radioligand binding assay using 
the serotonergic agonist [3H]LSD. No endogenous expression 
of [3H]LSD binding sites could be detected in P. pastoris clones 
which had been transformed with the control plasmid. Crude 
membranes of the yeast strain SMD1163 which had been trans- 
formed with pPIC9-5-HTsAmyc exhibited specific saturable 
binding of [3H]LSD with a K d of 1.9 _+ 0.26 nM (Fig. 2), and 
specific saturable binding of [3H]LSD could also be measured 
with whole cells. Scatchard transformation (Fig. 2) of the data 
obtained from the experiments on membranes indicated that 
the binding of [3H]LSD to the mouse 5-HTsA receptor expressed 
in P pastoris was best described by a model assuming a single 
class of equivalent and independent binding sites. The expres- 
sion level (B,~ax) in the recombinant SMD1163 clone was deter- 
mined to be =22 pmol/mg of membrane protein. 
To determine the pharmacological profile of the heterolo- 
gously expressed 5-HTsA receptor, bound [3H]LSD was dis- 
placed with various serotonergic drugs (Fig. 3). These com- 
pounds displayed the following rank order of potencies: ergo- 
tamine> 5-CT > methysergide > 5-HT > lysergic acid > 
bufotenine > yohimbine (Table 1), which is comparable to the 
data obtained for the 5-HTsA receptor expressed in Cos-7 cells 
[11]. None of the competition curves showed a biphasic profile 
(Fig. 3), indicating that [3H]LSD binding sites have a homoge- 
nous affinity to the above-mentioned drugs. 
3.4. Cellular localization of the 5-HT~ A receptor heterologously 
produced in E pastoris 
For cellular localization of the heterologously produced re- 
ceptor, recombinant yeast cells were fixed about 25 h after 
induction and embedded in plastic. Cells were analysed by the 
postembedding immunogold staining method. The monoclonal 
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Fig. 2. Saturation isotherms of [-~H]LSD binding to membranes pre- 
pared from P pastoris train SMDl163 transformed with pPIC9-5- 
HT~amyc. (Inset) Scatchard transformation f the data. Data are repre- 
sentative for three independent experiments with similar results with 
each point beeing measured in triplicate. 
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Fig. 3. Pharmacological profile of the 5-HTs. ~ receptor heterotogously 
expressed in recombinant P pastorh strain SMD1163 Plasmid pPIC9- 
5-HTsAmyc was used for transformation of P pastoris strain 
SMD1163. Competitive binding to the membranes was performed at 
a final [3H]LSD concentration f 1.6 nM. The 100% value corresponds 
to specific binding in absence of any compeptitor, the 0% value corre- 
sponds to the non-specific binding. Data are representative for two 
independent experiments, with each point being measured in duplicate. 
5-CT, 5-carboxamidotryptamine: 5-HT, 5-hydroxytryptamine. 
antibody 9El0 which specifically reacts against he c-no, c epi- 
tope fused to the receptor in combination with a gold-labeled 
anti-mouse serum was applied to thin sections obtained from 
the embedded cells, lmmunostaining of P. pastoris cells which 
expressed a 5-HTsA receptor that had not been c-myc tagged, 
only revealed background labeling, i.e. at the appropriate anti- 
body dilution (9El0; 1:2000) almost no labeling can be seen 
(Fig. 4A). Specific staining of different cell compartments, how- 
ever, was observed over cells which produced the c-myc tagged 
serotonin receptor. Gold particles could be observed over the 
rough endoplasmatic reticulum over cytoplasmic membrane 
vesicles and the vacuole, No strong distinct labeling occured 
over the plasma membrane. 
4. Discussion 
Considering the medical and pharmacological importance of
the G-protein coupled receptor family, a three-dimensional 
structure of one of these receptors would have a great impact. 
Attempts to study receptor function and structure have been 
hampered by the absence of pure populations of receptor. Nat- 
ural sources cannot provide the amount of protein needed for 
initial crystallization attempts and in addition they represent 
complex mixtures of cell types and also receptor subtypes which 
do not allow the purification of the receptor to homogeneity. 
The way to overcome this problem is to express the receptor 
gene of interest in a suitable xpression system thus allowing 
the production of a homogeneous population of receptor pro- 
tein. Expression levels of membrane proteins are usually poor 
in comparison to the expression levels which can be reached 
with soluble proteins. Therefore. large amounts of biomass are 
a prerequisite for purification attempts. Yeasts that grow fast 
on inexpensive media are in this task an interesting alternative 
to expression for example in insect cells using the baculovirus 
system or in mammalian cells. The best-characterized yeast 
S. cervisiae has been successfully used in this field, and reports 
about receptor expression i S. pombe are also available [24,25]. 
In the case of soluble proteins, the heterologous expression i  
P pastoris often resulted in higher expression levels than in 
S. cerevisiae [26]. 
Here, we tested the P. pastoris system as a tool for the 
expression of the 5-HTsA serotonin receptor. Three vector con- 
structs from which the 5-HTsA-receptor alone as well as in 
fusion to two different signal sequences could be functionally 
expressed, were examined. The signal sequences in this two 
constructs should enforce proper insertion into the ER mem- 
brane. The construct with the PHOI  signal sequence resulted 
in even lower expression levels as the construct with no modifi- 
cations at the N-terminus as revealed by radioligand binding 
assays. The plasmid construct using the S. cerevisiae ~z-factor 
signal sequence resulted in the highest expression level in 
P pastoris strain GSll5. This strain used for transformation 
and initial characterization f all constructs, is wild-type in 
respect o its protease content. The value of protease deficient 
strains for membrane protein expression i S. cervisiae has been 
described previously [20]. Therefore, plasmid pPIC9-5- 
HTsAmyc was used for further characterization f the heterolo- 
gously expressed 5-HTsA receptor in the protease deficient P. 
pastoris strain SMD1163. Whole cells as well as membranes 
prepared here from, exhibited saturable binding for [3H]LSD, 
a potent serotonergic agonist. Bound [3H]LSD could be dis- 
placed by a variety of unlabeled serotonin analogs. |t should 
be noted, however, that the KdOf = 1.9 nM and the K~'s for the 
different competitors differ from published values determined 
in transiently transfected mammalian cells by an order of mag- 
nitude. As has been discussed previously, a possible explana- 
tion for this discrepancy could be the lipid composition of the 
membranes surrounding the receptor molecules [20]. Neverthe- 
less, the pharmacological profile is virtually identical to the 
profile obtained after expression of the receptor in S. cerevisiae 
[15]. The receptor density of maximally =30,000 receptors per 
recombinant P pastoris cell corresponds to a value of more 
than 1 mg receptor/l of yeast culture, In comparison, the en- 
dogenous STE2 receptor of S. cerevisiae had approximately 
3000-8000 copies/cell [27], whereas the heterologously pro- 
duced roACh-receptor subtype ml and the D2s receptor had 
approximately 2-40 copies/cell and 500-1000 copies/cell, re- 
spectively [20,28]. The receptor level reached in membranes of
Table 1 
Pharmacological profile of the 5HTsA receptor heterologously ex- 
pressed in P pastoris strain SMDl163 transformed with pPIC9- 
5HT~,xmyc 
Ligand Ki (M) 
Ergotamine 3.8 + 0.5 x 10 -8 
5-Carboxamidotryptamine (5-CT) 5.5 + 0.6 x 10 -8 
Methysergide 5.0 + 2.4 x 10-7 
5-Hydroxytryptamine (5-HT) 1.1 + 0.8 x 10 -6 
Lysergic acid 2.0 + 0.8 x 10 _6 
Bulbtenine 2.9 + 0.6 x 10 ~6 
Yohimbine 1.2 + 0.1 x 10 -5 
K, values were calculated from the ICs0 obtained in the competition 
experiments depicted in Fig. 3. They were calculated from the ICso 
x.alues according to the equation K~ = ICs0(l + C/Ka), where C is the 
concentration f [3H]LSD and K d ( 1.9 nM) the equilibrium dissociation 
constant of [~H]LSD for the heterologously expressed 5HTs• receptor 
I see text). 
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Fig. 4. Cellular localization of the heterologously expressed 5-HTsA receptor by immunogold abeling Post-embedding immunogold staining of 
ultrathin sections from recombinant P pastoris strain SMD1163 cells either transformed with plasmid pHIL-D2-5-HTsA (A) or plasmid pPIC9-5- 
HTsAmyc (B,C,D). M, mitochondrium: N, nucleus; V, vacuole. 
recombinant P pastoris i=22 pmol/mg membrane protein) is 14 
times higher than the levels reported for transfected mammal- 
ian cells ( 1.6 pmol/mg membrane protein: [11]), about 1.4 times 
higher than the level reached in S. cerevisiae [15], and is in the 
range that can be reached in insect cells after infection with 
recombinant baculovirus (->30 pmol/mg membrane protein: 
[14]). Localization studies of the epitope-tagged receptor e- 
vealed that it was localized mainly in the internal membrane 
compartments of the yeast cells. Almost no labeling occurred 
over the plasma membrane, although the receptor is a natural 
resident of the plasma membrane. 
In conclusion, these results indicate that the Pichia pastori~ 
expression system might be of great value for the overexpres- 
sion of membrane proteins. The mouse 5-HTsA receptor 
heterologously expressed in this yeast is biologically active and 
suitable for further biochemical, pharmacological and biophys- 
ical studies. 
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